Insiders · RVMD

Mark A Goldsmith

Officer, Director at Revolution Medicines, Inc. (RVMD)

Mark A Goldsmith has filed 90 insider reports with the SEC since February 2021, as officer and director at Revolution Medicines, Inc. (RVMD) and director at Constellation Pharmaceuticals Inc (CNST). In the last 12 months Mark A Goldsmith sold $51.4M of stock on the open market. On September 15, 2026 Mark A Goldsmith filed a Form 144 notice and plans to sell 13,603 RVMD shares (~$2.77M). In the latest filing, on September 18, 2026, Mark A Goldsmith sold 13,988 shares of Revolution Medicines, Inc. (RVMD) for $2.79M at an average of $199.24.

Planned sale (Form 144)

  • Mark A Goldsmith plans to sell 13,603 RVMD shares (~$2.77M), around Sep 15, 2026. Notice filed Sep 15, 2026.

A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.

Filings
90
Companies
2
Bought on market
None
Sold on market
$71.3M

Companies where Mark A Goldsmith is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Revolution Medicines, Inc. logo
RVMD
Revolution Medicines, Inc.
Officer, Director253,342$71.3M$161.20Sep 18, 2026
Constellation Pharmaceuticals Inc logo
CNST
Constellation Pharmaceuticals Inc
Director0Jul 19, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Mark A Goldsmith with

Other insiders at the same companies

Questions about Mark A Goldsmith

What is Mark A Goldsmith's role at Revolution Medicines, Inc.?
Mark A Goldsmith reports to the SEC as officer and director at Revolution Medicines, Inc. (RVMD), according to the latest filing on September 18, 2026. Mark A Goldsmith has also filed as director at Constellation Pharmaceuticals Inc (CNST).
How many shares does Mark A Goldsmith own?
After the latest filing that states it, Mark A Goldsmith directly owned 253,342 shares of Revolution Medicines, Inc. (RVMD). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark A Goldsmith bought or sold stock recently?
The most recent open-market sale was on September 16, 2026: sold 13,988 shares of Revolution Medicines, Inc. (RVMD) for $2.79M at an average of $199.24.
How do I get alerts when Mark A Goldsmith files?
Follow Mark A Goldsmith on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark A Goldsmith filed 3 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Mark A Goldsmith (SEC CIK 0001246842). Totals count each trade once, skipping amendments whose original is on file, from Feb 3, 2021 on. View on SEC EDGAR · Get this as JSON